Open access · CC-BY
via OpenAlex
Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target
Delphine Garnier, Ophélie Renoult, Marie‐Clotilde Alves‐Guerra, François Paris, Claire Pecqueur
Frontiers in Oncology · 2019 · ▲ 155 citations
Abstract
Over the years, substantial evidence has definitively confirmed the existence of cancer stem-like cells within tumors such as Glioblastoma. The importance of Glioblastoma stem-like cells (GSCs) in tumor progression and relapse clearly highlights that cancer eradication requires killing of GSCs that are intrinsically resistant to conventional therapies as well as eradication of the non-GSCs cells since GSCs emergence relies on a dynamic process. The past decade of research highlights that metabolism is a significant player in tumor progression and actually might orchestrate it. The growing interest in cancer metabolism reprogrammation can lead to innovative approaches exploiting metabolic vulnerabilities of cancer cells. These approaches are challenging since they require overcoming the compensatory and adaptive responses of GSCs. In this review, we will summarize the current knowledge on GSCs with a particular focus on their metabolic complexity. We will also discuss potential approaches targeting GSCs metabolism to potentially improve clinical care.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fonc.2019.00118
- Canonical
- link ↗
- Fetched
- 2026-09-27 MST
Cite this
APA
Garnier, D., Renoult, O., Alves‐Guerra, M., Paris, F., & Pecqueur, C. (2019). Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target. <em>Frontiers in Oncology</em>. https://doi.org/10.3389/fonc.2019.00118
Vancouver
Garnier D, Renoult O, Alves‐Guerra M, Paris F, Pecqueur C. Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target. Frontiers in Oncology. 2019. doi:10.3389/fonc.2019.00118.
BibTeX
@article{delphine2019Gliobl,
title = {Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target},
author = {Delphine Garnier and Ophélie Renoult and Marie‐Clotilde Alves‐Guerra and François Paris and Claire Pecqueur},
journal = {Frontiers in Oncology},
year = {2019},
doi = {10.3389/fonc.2019.00118},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinics and Practice 2023
Open access · CC-BY
The Emerging Role of Senotherapy in Cancer: A Comprehensive Review
University Hospital, Brest 2018
Open access · US-GOV
Neuroendocrine Tumors of Patients Aged of 75 y or Over in the West of France
Aging and disease 2026
Citation only
Senescence and SASP in the Stromal Microenvironment of Breast Cancer: Dual Role in Progression and Therapeutic Options.
EBioMedicine 2021
Open access · CC-BY
Senescent T cells: a potential biomarker and target for cancer therapy
Genome Medicine 2023
Open access · CC-BY
Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing
Cells 2019
Open access · CC-BY